Note: the following material is for personal use only see below for



Download 3.95 Mb.
Page52/73
Date30.04.2018
Size3.95 Mb.
#47014
1   ...   48   49   50   51   52   53   54   55   ...   73

Subclinical Hypothyroidism


Labs: elevated serum TSH and normal T4 or free T4 concentration (and no symptoms)

Treatment: individualized / replacement recommended with TSH > 10 or > 5 with goiter or thyroid antibodies / otherwise, can just wait and see

Course: does not always lead to primary hypothyroidism / women with increased TSH and thyroid Ab’s have 5% annual incidence of overt hypothyroidism / those pts over 65 yrs with both findings usu. develop hypothyroidism within 4 yrs / euthyroidism with reset thyrostat may not progress to hypothyroidism (probably from subtle insult to thyroid gland)
Hypothyroidism of pregnancy

1-2% incidence of hypothyroidism in young women / hypothyroidism causes impaired cognitive development and increased pregnancy causes increase in levothyroxine requirement by 5th week gestation / recommendation is increase replacement dose by 30% at start of pregnancy and adjust based on TFT’s thereafter


Thyroiditis


  • I123 uptake usually decreased


Hashimoto’s thyroiditis

autoimmune disease / most common cause of hypothyroid in US / may have non-tender goiter (rubbery with scalloped borders) / can check for anti-microsomal Ab’s (also called anti-thyroperoxidase or TPO) / Pathology: Hurthle cells


Subacute granulomatous thyroiditis (DeQuervrain’s)

Presentation: pain, tenderness, symptoms of hyperthyroid (usu. takes about 6-8 weeks to achieve spontaneous remission) / often associated with viral illness (URI, etc.)



Diagnosis: clinical and/or I123 scan

Findings: increased free T4 or FTI but decreased I-123 uptake because of the follicular cells’ inability to concentrate iodine

Treatment: treat symptoms (NSAIDs, B-blockers, may need steroids) / PTU/M not effective
Subacute lymphocytic thyroiditis

common post-partum / unknown etiology / painless


Riedel’s thyroiditis (Struma)

unknown etiology / can compress neck structures and/or cause hypothyroidism / fibrosis of gland / PET-scan may be useful in diagnosis


Medications: amiodarone-induce (side effect), iodine or T4 (factitious or overdose)

Other causes: TSH-secreting pituitary adenoma, hydatidiform moles, choriocarcinomas (hCG secretion), ovarian teratomas, metastatic follicular thyroid carcinomas


Thyroid Neoplasms (thyroid nodules)
Common, occur in 5% of adults

Presentation: nodules usually painless unless they ulcerate or compress other things

Diagnosis: if incidentally discovered by imaging, small (< 1 cm), normal TSH, asymptomatic, no h/o radiation or thyroid cancer, can watch and re-evaluate in 6 months, otherwise…

I-123 radioactive uptake scan (cold has 5-10% chance of malignancy  probably need to do FNA (15% will be suspicious and require surgical evaluation) / ultrasound shows cystic or solid (but still probably will need FNA or Bx) / pentagastrin test for medullary carcinoma

Ddx: follicular adenoma, multinodular goiter, colloid nodule, Hashimoto’s, cyst, lymphoma, mets, parathyroid

  • 90% of all thyroid nodules benign (incidental, < 1 cm even more likely benign)

  • nodules increase with age (younger patient means increased chance of malignancy)

  • nodules usually cold (do not take iodine)

Treatment: Iodide may be used to decrease vascularity (pre-op for thyroid resection) / excision +/- lymph node dissection / if thyroid completely removed, then lifelong exogenous T4 to suppress TSH production (keep TSH at barely detectable levels) / follow-up I-123 uptake scan to ensure no active thyroid tissue present

Complications of surgery: 50% becoming hypothyroid (complications: recurrent and superior laryngeal nerve paralysis, recurrence and hypoparathyroid), may have to remove hyoid to remove all accessory tissue
Follicular adenoma

encapsulated / usually euthyroid / Treatment: as above


Thyroid Carcinomas
Papillary carcinoma - good prognosis

1st in U.S. / indolent (slow growth), +/- bilateral

Pathology: ground-glass nuclei, longitudinal nuclei, psammoma bodies

lymphatic spread / previous irradiation gives a 2-fold higher risk

Exam: may have lymphadenopathy (mets), even with normal thyroid palpation
Follicular carcinoma - bad prognosis

2nd in U.S. / vascular spread (brain, bone, etc) / middle aged women / may mimic follicular adenoma
Medullary carcinoma - bad prognosis

3rd in U.S. / lymphatic spread / bilateral / parafollicular C-cells / secrete calcitonin / FH of disease is better / isolated or as part of MEN II and III
Undifferentiated (anaplastic) - extremely bad prognosis

radiation + chemotherapy is only palliative


Parathyroid
Physiology
Total serum calcium 9 mg/dl – bound to proteins (albumin) and PO4 / regulated indirectly

Ionized serum calcium 4.5 mg/dl – regulated directly



PTH increases bone resorption (osteoclast activation)

increases serum calcium

lowers fractional reabsorption of PO4 from kidney (normally set at 80-90%)



increases formation of 1,25-OH – increases Ca and PO4 absorption in GI

increases urinary cAMP


Vitamin D

causes GI absorption of PO4, Ca and increased renal PO4 and Ca reabsorption, and lowers PTH


Vitamin D deficiency

occurs in 25% of elderly / affects seen in children more acutely due to lower calcium stores in bones/ may cause lowered Ca and PO4 leading to secondary hyper PTH



Reasons: lower intake, lack of sun exposure, direct renal damage (conversion enzymes), anticonvulsants (increased inactivation)

Labs: 25-OH – 1000 fold higher than 1,25-OH – useful to measure vitamin D deficiency

1,25-OH – useful for diagnosis hypercalcemia caused by secretory tumor



Treatment: 1000-2000 vitamin D / 1 to 1.5 g Ca supplement
Calcitonin increases renal excretion of calcium / increases bone formation

[more like an escape mechanism / not a primary regulator of serum calcium]


PTHrP protein functions identically to PTH causing hypercalcemia / can be measured directly by lab
Hyperparathyroidism (other causes of hypercalcemia)

Not uncommon (3 in 1000 middle-age women) / female 2x > male (usually after puberty)

Causes: primary adenoma (90%), secondary adenoma, carcinoma, MEN I (10%)

Increased PTH: pancreatitis, nephrolithiasis, nephrocalcinosis, gout, pseudogout, HTN, PUD



Presentation: can present in hypercalcemic crisis

  • Bones: renal stones, UTI, renal failure, nephrocalcinosis (less common)

  • Stones: aches, arthralgias, pseudogout

  • Abdominal groans: dehydration, constipation, pancreatitis, PUD (CA stimulates gastrin secretion), nausea, vomiting

  • Psychic overtones: anorexia, personality changes, polyuria/polydipsia

  • Fatigue: muscle fatigue or atrophy, lassitude

Labs:

  • Hypercalcemia

  • Hypercalciuria only seen in 2/3 of cases

  • Alk phos only with significant bone disease

  • serum chloride ↑ due to PTH-induced bicarbonaturia (more consistent finding than hypophosphatemia)


Parathyroid hyperplasia

chief cell - solid area of chief cells, reduced fat

clear cell - uniform distribution of clear cells, reduced fat
Parathyroid adenoma

common, 80% parathyroid neoplasms / chief cells (no fat within capsule) / surrounded by normal or atrophic gland, fat cells / usually secretes PTH (hypercalemia)

Exam: rarely find palpable neck mass / brown tumors (osteoclasts clump in bone causing focal swelling)

Diagnosis: U/S, CT, thallium, venous sampling / radiography is positive in 60-80% of cases / selective venous catheterization and PTH detection is second line

Ddx: ectopic PTH, sarcoid, milk alkali, HCTZ, vitamin D/A overdose, hyperthyroid

multiple myeloma, Paget’s, Addisonian crisis, familial HH?



Treatment: resection for hyperplasia (leave ½ of 1 gland) / adenoma (remove only 1 gland) / can cause ‘hungry bones’ phenomenon (hypocalcemia) – perioral numbness, Chvostek’s, seizures / 5% recur (can re-operate)
Parathyroid carcinoma

rare / invasive / squamous / mets to lung, head/neck, kidney, ovary
As part of multiple endocrine neoplasia (see other)
Secondary hyperparathyroidism (renal osteodystrophy)


  • CRF  ↑ serum PO4  CaPO4 deposition  ↓ serum Ca  ↑ PTH release




  • ↓ vitamin D-1-25-OH (due to renal failure)  ↓ serum Ca  ↑ PTH release


Complications: osteodystrophy, myopathy, can get severe muscle atrophy

Treatment: vitamin D supplementation, ↓ PO4 intake, PO4 binders (calcium carbonate)


Download 3.95 Mb.

Share with your friends:
1   ...   48   49   50   51   52   53   54   55   ...   73




The database is protected by copyright ©ininet.org 2024
send message

    Main page